metformin has been researched along with Right Ventricular Dysfunction in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| McNair, BD | 1 |
| Polson, SM | 1 |
| Shorthill, SK | 1 |
| Yusifov, A | 1 |
| Walker, LA | 1 |
| Weiser-Evans, MCM | 1 |
| Kovacs, EJ | 1 |
| Bruns, DR | 1 |
1 other study available for metformin and Right Ventricular Dysfunction
| Article | Year |
|---|---|
Metformin protects against pulmonary hypertension-induced right ventricular dysfunction in an age- and sex-specific manner independent of cardiac AMPK.
Topics: AMP-Activated Protein Kinases; Animals; Disease Models, Animal; Female; Heart Failure; Hypertension, | 2023 |